throbber
12I2&2015
`
`Lqin Plnmaceuicds, hc.
`
`"Imus ‘men 3
`E
`.
`.
`.
`.
`.
`.
`.
`.
`.
`.
`.
`.
`.
`.
`.
`
`.
`
`F
`.
`.
`
`.
`
`me’
`.
`.
`.
`.
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`. .. .
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`. ..
`
`Our mission is to become a transnational pharmaceutical company
`through the development and introduction of a wide portfolio of branded
`.. . ‘I
`I
`.
`“_
`1‘
`
`
`
`Who We Are
`
`
`
`
`
`
`
`is the U.S. wholly owned subsidiary of Lupin
`Lupin Pharmaceuticals, Inc.
`Limited, which is among the top five phannaceutical companies in India.
`Through our sales and marketing headquarters in Baltimore, MD, Lupin
`Phannaoeuticals, Inc. is dedicated to delivering high—qua|ity, branded and
`generic medications trusted by healthcare professionals and patients
`across geographies.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`is strongly research
`India,
`Lupin Limited, headquartered in Mumbai,
`focused. It has a program for developing New Chemical Entities. The
`
`company has a state-of-the-art R&D center in Pune and is a leading global
`
`player in Anti-TB, Cephalosporins (anti-infectives) and Cardiovascular drugs
`(ACE-inhibitors and cholesterol
`reducing agents) and has a notable
`
`presence in the areas of diabetes, anti-inflammatory and respiratory
`therapy.
`
`We are building on our parent company's strengths of vertical integration
`in discovery research, process chemistry, active pharmaceutical ingredient
`production,
`formulation development
`and regulatory filings. Lupin
`Pharmaceuticals, Inc. is committed to achieving its vision and mission of
`becoming an innovation led transnational phannaceutical company.
`
`Vinita Gupta, CEO of Lupin Pharmaceuticals, Inc. says "founded on the
`strengths of our parent company Lupin Limited, Lupin Phannaceuticals,
`Inc. intends to bring a portfolio of generics as well as branded products to
`the US market.“
`
`For the financial year ended 31st March 2015, Lupin's Consolidated
`turnover and Profit after Tax were Rs. 125,997 million (USD 2.06 billion)
`and Rs. 24,032 million (USD 393 million) respectively.Please visit
`http://www.lupinwor|d.com for more infonnation.
`
`A
`
`L
`
`Copyright © 2010, Lupin Pharmaceuticals, Inc., All Rights Reserved.
`
`1’38° 1 9‘ 1
`IIlp1Iwww.Iqlr|ilImaoe|lIais.oanIzixntflrn
`
`SENJU EXHIBIT 2263
`LUPIN v. SENJU
`IPR20l5-01100
`
`1I1

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket